Troutman Pepper Hamilton Sanders advised Onkos Surgical, Inc. on the deal. Onkos Surgical, Inc., a leading innovator of solutions for musculoskeletal oncology and complex orthopedic conditions,...
Onkos Surgical’s Acquisition of JTS Extendible Prosthesis
Hikma Pharmaceuticals’ $375 Million Acquisition of Custopharm
Troutman Pepper advised Hikma Pharmaceuticals PLC on the deal. Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, has acquired Custopharm Inc. from Water Street Healthcare Partners, following...
Apnimed’s Series C Financing
Troutman Pepper advised Apnimed on the deal. Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related...
Botanix Pharmaceuticals Limited’s Acquisition of Sofpironium Bromide
Troutman Pepper advised Botanix Pharmaceuticals Limited on the deal. Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel,...
Trevena’s Royalty-Based Financing Agreement with R-Bridge Healthcare Fund
Troutman Pepper advised Trevena on the deal. Trevena, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system...
Century Therapeutics’ Collaboration with Bristol Myers Squibb
Troutman Pepper advised Century Therapeutics on the deal. Century Therapeutics (NASDAQ: IPSC) has announced a research collaboration and license agreement with Bristol Myers Squibb (NYSE: BMY)...
GE Healthcare’s Acquisition of Zionexa
Stephenson Harwood, De Marcellus and Disser, Mercure Avocats, Troutman Pepper advised GE Healthcare on the transaction while Goodwin Procter LLP advised the shareholders of Zionexa. Zionexa,...
Gamma Biosciences’ Acquisition of BioMagnetic Solutions
Troutman Pepper Hamilton Sanders LLP advised BioMagnetic Solutions on the deal. BioMagnetic Solutions was recently acquired by Gamma Biosciences, a life sciences tools platform created by KKR....